RAI therapy generally affects only the thyroid and does not harm other parts of the body
Many of the pipeline drugs will launch at brand pricing ($1,000 to $1,500 per month) and wont be compoundable for several years
That said, semaglutide is often a great place to start, especially for those with hypothyroidism, because its well-studied and widely available
FDA Fast Track DesignationUSEurope CRB-913CRB-913 / CB1R / peripherally restricted oral CB1 inverse agonist / Obesity/metabolic diseaseObesity and related conditionsPhase 1 in progress12-week dose-range study in obesity planned mid-2026 2assets Vispacabtagene regedleucelCB-010 / vispa-cel / CD19 / Allogeneic anti-CD19 CAR-T cell therapy
Alan were amazing
Cao S, Yan B, Lu Y, Zhang G, Li J, Zhai W, Guo W, Zhang S